# A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

> **NCT01250379** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 494 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** bevacizumab [Avastin]
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT01250379
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-12
- **Final completion:** 2015-03
- **Target enrollment:** 494 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250379, "A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01250379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*